Prevalence of metabolic syndrome among 40- and 50-year-old inhabitants of Wroclaw, Poland

Annals of Agricultural and Environmental Medicine

Volumn 19, Issue 3, 2012, Pages 551-556

  Ilow, Rafał ^a   Regulska Ilow, Bozena ^a   Rózańska, Dorota ^a   Kowalisko, Alicja ^b   Biernat, Jadwiga ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Cardiology Centre Pro Corde   (Poland)

Author keywords

Cardiovascular disease (CVD); Metabolic syndrome; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; POLAND; PREVALENCE; SEX RATIO; WAIST CIRCUMFERENCE;

AGE FACTORS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY SIZE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIET SURVEYS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLAND; PREVALENCE; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; URBAN POPULATION; WAIST-HIP RATIO;

EID: 84866641115     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Popkin BM, Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes. 2004; 28: S2-S9.
2. Shaw JE, Sicree RA, Zimmet PZ. Diabetes Atlas. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pr. 2010; 87: 4-14.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
4. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Organization 1999.
5. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16: 442-443.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
8. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
9. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
10. Wyrzykowski B: Zespół metaboliczny w praktyce klinicznej. Vol. 1. Via Medica, Gdańsk 2010. p.137, 139-150 (in Polish).
11. Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome. Diabetes Care. 2004; 27: 1011-1012.
12. Reaven GM. Just being alive is not good enough. Clin Chem. 2005; 51: 1354-1357.
13. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005; 51: 931-938.
14. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006; 83: 1237-1247.
15. Gale EAM. The myth of the metabolic syndrome. Diabetol. 2005; 48: 1679-1683.
16. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371: 1927-1935.
17. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
18. Kahn R. Metabolic syndrome-what is the clinical usefulness? Lancet 2008; 371: 1892-1893.
19. Federspil G, Nisoli E, Vettor R. A critical reflection on the definition of metabolic syndrome. Pharmacol Res. 2006; 53: 449-456.
20. Grundy SM. The metabolic syndrome still lives. Clin Chem. 2005; 51: 1352-1357.
21. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28: 629-636.
22. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk. A systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56: 1113-1132.
23. Guize L, Pannier B, Thomas F, Bean K, Jégo B, Benetos A. Recent advances in metabolic syndrome and cardiovascular disease. Arch Cardiovasc Dis. 2008; 101: 577-583.
24. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006; 119: 812-819.
25. Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010; 26: 713-719.
26. Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R. Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int J Public Health. 2011; DOI: 10.1007/s00038-011-0244-x
27. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel K-H. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2007; 6: 22, DOI: 10.1186/1475-2840-6-22.
28. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28: 2745-2749.
29. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E, Chittleborough C, et al. Population comparison of two clinical approaches to the metabolic syndrome. Diabetes Care. 2005; 28: 2777-2779.
30. Wyrzykowski B, Zdrojewski T, Sygnowska E, Biela U, Drygas W, Tykarski A, et al. Epidemiologia zespołu metabolicznego w Polsce. Wyniki programu WOBASZ. (Epidemiology of metabolic syndrome in Poland. Results of the WOBASZ program). Kardiol Pol. 2005; 63 (6 Suppl. 4): S1-S4 (in Polish).
31. Janszky I, Vatten L, Romundstad P, Laugsand LE, Bjørngård JH, Mańczuk M, Zatoński WA. Metabolic syndrome in Poland-the PONS Study. Ann Agric Environ Med 2011; 18: 270-272.
32. Wyrzykowski B, Bandosz P, Zdrojewski T. Ocena cze{ogonek}stości wyste{ogonek}powania zespołu metabolicznego w Polsce. (Prevalence of metabolic syndrome in Poland) Kardioprofil. 2006; 4: 3-11 (in Polish).